Influence of Tiaojing Decoction on Quality of Follicle and Hormone Secretion on Polycystic Ovary Syndrome

WU Huo-man; LI Zhao-ping; WANG Yun-qi; XIANG Li-juan

doi:10.13422/j.cnki.syfjx.2014180200

您当前的位置：

首页 >

文章列表页 >

Influence of Tiaojing Decoction on Quality of Follicle and Hormone Secretion on Polycystic Ovary Syndrome

更新时间：2024-01-04

- Influence of Tiaojing Decoction on Quality of Follicle and Hormone Secretion on Polycystic Ovary Syndrome
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 18, Pages: 200-203(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2014180200
  CLC： R271.9
- Published：2014
- 稿件说明：
移动端阅览
WU Huo-man, LI Zhao-ping, WANG Yun-qi, et al. Influence of Tiaojing Decoction on Quality of Follicle and Hormone Secretion on Polycystic Ovary Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(18): 200-203.
DOI：

WU Huo-man, LI Zhao-ping, WANG Yun-qi, et al. Influence of Tiaojing Decoction on Quality of Follicle and Hormone Secretion on Polycystic Ovary Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(18): 200-203. DOI： 10.13422/j.cnki.syfjx.2014180200.

摘要

目的：探讨调经汤治疗多囊卵巢综合征不孕（PCOS）的疗效及作用机制。方法：将84例PCOS 患者随机按数字表法分为调经汤组和对照组各42例。对照组采用炔雌醇环丙孕酮片+枸橼酸氯米芬+注射用尿促性素治疗；调经汤组在对照组治疗的基础上加用调经汤。两组疗程均为3个月经周期。采用B超监测卵泡发育情况，并测定主导卵泡膜血流，记录搏动指数（PI）和阻力指数（RI）；检测人绒毛膜促性腺激素（HCG）注射日，黄体生成素（LH）、血清睾酮（T）、雌二醇（E2）水平和卵泡刺激素（FSH）水平；检测治疗前后空腹血糖（FBG）、空腹胰岛素（FINS）水平和瘦素（LP）水平，并计算胰岛素抵抗指数（HOMA-IR）；记录月经恢复率、排卵率、妊娠率。结果：调经汤组月经恢复率、排卵率和妊娠率为92.86%，83.33%和57.14%分别优于对照组的73.81%，61.90%和35.71%（P<0.05）。治疗后两组PI比治疗前有明显上升，调经汤组高于对照组（P<0.01）；治疗后两组RI较治疗前下降，调经汤组低于对照组（P<0.01）；治疗后调经汤组FSH，LH和E2水平高于对照组（P<0.01），血清睾酮水平低于对照组（P<0.01）；治疗后两组FINS，LP，IR均比治疗前下降，调经汤组治疗后FINS，LP，IR低于对照组（P<0.05）。结论：在西医常规治疗的基础上，调经汤能改善卵巢血流，提高卵泡质量，并能改善高雄激素血症和胰岛素抵抗，提高了排卵率和妊娠率。

Abstract

Objective: Curative effect and mechanism of Tiaojing decoction on polycystic ovary syndrome(PCOS) were investigated. Method: Eighty-four patients with PCOS were randomly divided into control groupand Tiaojing decoction group (42 cases

respectively) by random number table. Patients in control group received ethinylestradiol and cyproterone acetate tablets

clomifene citrate and menotrophin injection. Based on the treatment of control group

Tiaojing decoction was added in Tiaojing decoction group. Course of treatment in two groups were 3 menstrual cycles. Condition of follicular development was monitored by B-ultrasonic wave and the blood flow of follicularis membrane was also detected

pulsatility index (PI) and resistance index (RI) were recorded. And levels of human chorionic gonadotropin(HCG)

luteinizing hormone(LH) (injection day)

serum testosterone(T)

estradiol(E2) and follicle-stimulating hormone(FSH) were detected. Levels of fasting blood-glucose(FBG)

fasting insulin(FINS) and leptin(LP) were detected

and homeostasis model assessment of insulin resistance(HOMA-IR) was calculated before and after treatment. Rates of menstruation recovery

ovulation and pregnancy were recorded. Result: Rates of menstruation recovery

ovulation and pregnancy in Tiaojing decoction group were 92.86%

83.33% and 57.14% respectively

which were superior to those in control group(73.81%

61.90% and 35.71%) (P<0.05). Compared with that before treatment

PI in both groups increased

and which in Tiaojing decoction group was higher than in control group (P<0.01). Compared with that before treatment

RI in both groups decreased

and which in Tiaojing decoction group was lower than in control group (P<0.01). Levels of FSH

LH and E2 in Tiaojing decoction group were higher than those in control group (P<0.01)

and level of serous testosterone was lower than in control group (P<0.01). After treatment

compared with those before treatment

FINS

LP and IR in both groups decreased

and which in Tiaojing decoction group were lower than those in control group(P<0.05). Conclusion: Based on the routine western medicine treatment

Tiaojing decoction can ameliorate blood flow ovary

improve quality of follicle

ameliorate hyperandrogenism and insulin resistance and improve rates of ovulation and pregnancy.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Modified Cangfu Daotantang on Metabolism and Pregnancy in Patients with Polycystic Ovary Syndrome

Dihuang Wan Combined with Xionggui Erchen Tang on Hyperandrogenism and Polycystic Ovary Syndrome with Syndrome of Kidney Deficiency and Blood Stasis

Mechanism of Kidney-tonifying and Liver-regulating Cyclical Therapy and Formula in Improving Endometrial Receptivity during "Implantation Window" in Rats with Polycystic Ovary Syndrome via miR-140-5p/VEGF Pathway

Mechanism of Modified Guishenwan in Regulating AMPK/Akt/Nrf2 Pathway to Improve Glucose and Lipid Metabolism and Oxidative Stress in Polycystic Ovary Syndrome Rats

Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway

Related Author

Peng-peng XIE

Lei ZENG

Jing-wei YU

Yan-hong FU

LIU Yu-lan

SONG Chun-xia

BAO Hong-ling

XU Hong-yan

Related Institution

Maternal and Child Health Hospital of Huadu District in Guangzhou

Panyu Maternal and Child Care Service Centre of Guangzhou

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Guangzhou Women and Children's Medical Center

Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases， Hunan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰